Rigel Pharmaceuticals (RIGL) EPS (Weighted Average and Diluted): 2009-2024
Historic EPS (Weighted Average and Diluted) for Rigel Pharmaceuticals (RIGL) over the last 10 years, with Dec 2024 value amounting to $0.99.
- Rigel Pharmaceuticals' EPS (Weighted Average and Diluted) rose 108.57% to $1.46 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.18, marking a year-over-year increase of 2709.09%. This contributed to the annual value of $0.99 for FY2024, which is 168.75% up from last year.
- Per Rigel Pharmaceuticals' latest filing, its EPS (Weighted Average and Diluted) stood at $0.99 for FY2024, which was up 168.75% from -$1.44 recorded in FY2023.
- In the past 5 years, Rigel Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of $0.99 in FY2024 and a low of -$3.44 during FY2022.
- Over the past 3 years, Rigel Pharmaceuticals' median EPS (Weighted Average and Diluted) value was -$1.44 (recorded in 2023), while the average stood at -$1.30.
- Per our database at Business Quant, Rigel Pharmaceuticals' EPS (Weighted Average and Diluted) plummeted by 3,027.27% in 2022 and then skyrocketed by 168.75% in 2024.
- Yearly analysis of 5 years shows Rigel Pharmaceuticals' EPS (Weighted Average and Diluted) stood at -$0.18 in 2020, then skyrocketed by 38.89% to -$0.11 in 2021, then slumped by 3,027.27% to -$3.44 in 2022, then surged by 58.14% to -$1.44 in 2023, then skyrocketed by 168.75% to $0.99 in 2024.